A novel oral therapy that inhibits the interleukin-23 inflammatory pathway provided control of moderate-to-severe psoriasis ...

New details have emerged about what Regeneron is planning for the Saratoga Springs site it acquired last year.

Global drug stocks rally as the FDA names Richard Pazdur, its top cancer drug regulator, as the head of its influential ...

Q3 2025 Earnings Call November 12, 2025 4:30 PM ESTCompany ParticipantsBenjamin Zeskind - Co-Founder, President, CEO ...

Williams & Connolly, a General Litigation Department of the Year finalist, notched several victories before the U.S. Supreme ...

Alvotech ( ($ALVO) ) has shared an announcement. On November 10, 2025, Alvotech announced that the UK High Court ruled in its favor, rejecting an ...

Announced extraordinary 86% overall survival at 9 months in first-line pancreatic cancer patients treated with atebimetinib + mGnP - - Raised $225 million of financing, including $25 million private ...

A well-tolerated antisense oligonucleotide yielded significant reductions in severe hypertriglyceridemia while lowering risk for acute pancreatitis in two phase 3 trials.

Chelsea Cirruzzo is a Washington correspondent at STAT, where she covers HHS. You can reach Chelsea on Signal at chelseacirruzzo.42. Daniel Payne reports on how the health industry and Washington ...

With sluggish pharmaceutical sales in the third quarter coming in below analysts’ expectations, Bayer is acutely aware of the challenges facing its key unit. | Despite the largely stagnant performance ...

Total revenues in the first nine months of the year were $420 million, a 24% increase from the same period last year Product ...